SKYRIZI- risankizumab-rzaa injection
injection, for subcutaneous use
|What is the most important information I should know about SKYRIZI?
SKYRIZI may cause serious side effects, including:
Infections. SKYRIZI may lower the ability of your immune system to fight infections and may increase your risk of infections. Your healthcare provider should check you for infections and tuberculosis (TB) before starting treatment with SKYRIZI and may treat you for TB before you begin treatment with SKYRIZI if you have a history of TB or have active TB. Your healthcare provider should watch you closely for signs and symptoms of TB during and after treatment with SKYRIZI. Tell your healthcare provider right away if you have an infection or have symptoms of an infection, including:
|○ fever, sweats, or chills|
○ shortness of breath
○ blood in your mucus
|○ muscle aches|
○ warm, red, or painful skin
or sores on your body
different from your
|○ weight loss
○ diarrhea or stomach pain
○ burning when you urinate
or urinating more often
|See “What are the possible side effects of SKYRIZI?” for more information about side effects.|
|What is SKYRIZI?
SKYRIZI is a prescription medicine used to treat adults with moderate to severe plaque psoriasis who may benefit from taking injections or pills (systemic therapy) or treatment using ultraviolet or UV light (phototherapy).
It is not known if SKYRIZI is safe and effective in children under 18 years of age.
|Before using SKYRIZI, tell your healthcare provider about all of your medical conditions, including if you:
|How should I use SKYRIZI?
See the detailed “Instructions for Use” that comes with SKYRIZI for information on how to prepare and inject a dose of SKYRIZI, and how to properly throw away (dispose of) used SKYRIZI prefilled pen or prefilled syringe.
|What are the possible side effects of SKYRIZI?
SKYRIZI may cause serious side effects. See “What is the most important information I should know about SKYRIZI?”
The most common side effects of SKYRIZI include:
|These are not all of the possible side effects of SKYRIZI. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.|
|How should I store SKYRIZI?
|General information about the safe and effective use of SKYRIZI
Medicines are sometimes prescribed for purposes other than those listed in a Medication Guide. Do not use SKYRIZI for a condition for which it was not prescribed. Do not give SKYRIZI to other people, even if they have the same symptoms that you have. It may harm them. You can ask your healthcare provider or pharmacist for information about SKYRIZI that is written for health professionals.
|What are the ingredients in SKYRIZI?
Active ingredient: risankizumab-rzaa
SKYRIZI 150 mg/mL inactive ingredients: acetic acid, polysorbate 20, sodium acetate trihydrate, trehalose dihydrate, and Water for Injection, USP.
SKYRIZI 75 mg/0.83 mL inactive ingredients: disodium succinate hexahydrate, polysorbate 20, sorbitol, succinic acid, and Water for Injection, USP.
Manufactured by: AbbVie Inc., North Chicago, IL 60064, U.S.A.
US License Number 1889
SKYRIZI® is a registered trademark of AbbVie Biotechnology Ltd.
© 2019-2021 AbbVie Inc.
For more information, call 1-866-SKYRIZI (1-866-759-7494) or go to www.SKYRIZI.com.
|This Medication Guide has been approved by the U.S. Food and Drug Administration.|